We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFGH
2651
DELISTED
American Financial Group, Inc. 6.000% Subordinated Debentures due 2055
AFGH
$0 ﹤0.01%
7
WMGI
2652
DELISTED
Wright Medical Group Inc
WMGI
-792,903
Closed -$16.4K
ETFC
2653
DELISTED
E*Trade Financial Corporation
ETFC
-24,455
Closed -$1.07K
BREW
2654
DELISTED
Craft Brew Alliance, Inc.
BREW
-83
Closed
PGNX
2655
DELISTED
Progenics Pharmaceuticals Inc
PGNX
-8,262
Closed -$41
WBC
2656
DELISTED
WABCO HOLDINGS INC.
WBC
$0 ﹤0.01%
2
-8
-80% -$1.08K
UNT
2657
DELISTED
UNIT Corporation
UNT
$0 ﹤0.01%
150
TGE
2658
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
-50,500
Closed -$1.02K
CYOU
2659
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$0 ﹤0.01%
95
RARX
2660
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-3,350
Closed -$79
OMN
2661
DELISTED
OMNOVA Solutions Inc.
OMN
$0 ﹤0.01%
3
DERM
2662
DELISTED
Dermira, Inc.
DERM
-119
Closed
GWR
2663
DELISTED
Genesee & Wyoming Inc.
GWR
-143
Closed -$15
CARB
2664
DELISTED
Carbonite Inc
CARB
-613
Closed -$9
AFGE.CL
2665
DELISTED
American Financial Group, Inc 6 % Subordinated Debentures due 2054 Called for Redemption
AFGE.CL
-7
Closed
CRZO
2666
DELISTED
Carrizo Oil & Gas Inc
CRZO
-1,838,023
Closed -$15.8K
ASNA
2667
DELISTED
Ascena Retail Group, Inc.
ASNA
$0 ﹤0.01%
39
-1
-3% -$8
ONCE
2668
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-9,000
Closed -$872
AEH.CL
2669
DELISTED
Aegon NV 6.375% Perpetual Capital Securities Called for Redemption
AEH.CL
-3,000
Closed -$78
SWJ.CL
2670
DELISTED
STANLEY BLACK & DECKER, INC. 5.75% Junior Subordinated Debentures due 2052
SWJ.CL
-600
Closed -$15
STI
2671
DELISTED
SunTrust Banks, Inc.
STI
-27,823
Closed -$1.91K
CBM
2672
DELISTED
Cambrex Corporation
CBM
-804
Closed -$47
VIAB
2673
DELISTED
Viacom Inc. Class B
VIAB
-1,263
Closed -$30
JPM.PRA.CL
2674
DELISTED
JPMORGAN CHASE & CO. Depositary Shares, each representing a 1/400 interest in a share of 5.45% Non-C
JPM.PRA.CL
-1,700
Closed -$43
ORIT
2675
DELISTED
Oritani Financial Corp. New
ORIT
-766
Closed -$13

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.